Company Filing History:
Years Active: 2021-2025
Title: Kristin Comella: Innovator in Regenerative Medicine
Introduction
Kristin Comella is a prominent inventor based in Weston, FL (US). She has made significant contributions to the field of regenerative medicine, particularly through her innovative research and patented technologies. With a total of 2 patents, Comella is recognized for her work in enhancing therapeutic activities of fibroblasts and promoting angiogenesis.
Latest Patents
Comella's latest patents include groundbreaking methods for stimulating angiogenesis using fibroblast-derived exosomes. This invention outlines techniques for administering membrane vesicles to treat conditions where angiogenesis is beneficial. The methods involve local or systemic administration of exosomes, which can augment regenerative processes such as hematopoiesis, angiogenesis, and neurogenesis.
Another notable patent focuses on enhancing the therapeutic activity of fibroblast cellular populations. This patent discloses various compositions and protocols for pre-treating fibroblasts with growth factors, platelet-rich plasma, or culturing them under hypoxic conditions. These advancements provide valuable means for assessing fibroblast activity in vitro, including wound repair assays and cytokine production.
Career Highlights
Throughout her career, Kristin Comella has worked with several companies, including Spinalcyte, LLC and Figene, LLC. Her expertise in regenerative medicine has positioned her as a leader in the field, contributing to the development of innovative therapies that harness the power of fibroblasts.
Collaborations
Comella has collaborated with notable professionals in her field, including Pete O'Heeron and Thomas E Ichim. These partnerships have furthered her research and expanded the impact of her inventions.
Conclusion
Kristin Comella's contributions to regenerative medicine through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in therapeutic applications, showcasing the potential of fibroblast technology in medical treatments.